Compare BridgeBio Pharma Inc (BBIO) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs NRG Energy Inc — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while NRG Energy Inc trades at $120.98 (market cap $24.83B). The key difference: NRG Energy Inc is the larger of the two by market cap, and NRG Energy Inc pays a 1.61% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | NRG | |
|---|---|---|
Market Cap | $16.36B | $24.83B |
Sector | Health | Utilities |
52-Week High | $90.17 | $184.03 |
52-Week Low | $47.29 | $117.04 |
Enterprise Value | $18.14B | $48.79B |
Dividend Yield | — | 1.61% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
